Table 1

Data of patients enrolled in the study

No

Age

Sex

Primary tumor

Measurement of disease

Metastases

Therapy between primary surgery and start of diet

1

47

f

Ovarian cancer

CT, CA 125

LI, LN, PC

10 × Taxol/Carboplatin; 10 × Hycamptin

2

46

f

Breast Cancer

PET

MPE, AS

Radiatio, 6 × [CMF]; 12 × [Epirubicin/Cyclophosphamid[, 14 × [Taxotere[, 2 × [Gemcetabine]

3

48

f

Granulosa cell tumor

CT, PET, Inhibin

LI, MI

6 × [Carboplatin/Epirubicin/Cyclophosphamid], 3 × Hemihepatectomy

4

30

f

Parotis carcinoma

CT

LO

Multiple surgery; Radiation; 6 × [Paclitaxel/Cisplatin]

5

62

f

Ovarian Cancer

US, CA 125

PC, FIGO IV

? × [Taxol/Carboplatin]

6

38

f

Osteosarcoma (jaw)

CT

LO

Multiple surgery

7

51

m

Oesophagus carcinoma

CT

LI, LN, MPE

2 × [Radiotherapy+Cisplatin/5-FU]; 2 × [Cisplatin/5-FU]; 7 × [Doxotaxel]

8

65

f

Pancreas carcinoma

MRI

LI

6 × [Gemcetabine], Immunotherapy (Survivin)

9

33

m

Thyroid carcinoma

US, CT, Calcitonin

LI, BO

Sanostatin, Interferon

10

50

m

Pancreas carcinoma

PET

LI

CapRI-Study branch A (Radiotherapy, Cisplatin/5-FU, IFN-alpha)

11

64

f

Thyroid carcinoma

CT, TG

LU, LN

Radio-Jod Therapy, Sanostatin

12

42

f

Colon carcinoma

PET

LI, LU

6 × Radiotherapie (38,6 GBq I-131); Avastin; ? × [Cisplatin/Carboplatin]

13

54

f

Endometrial cancer

CT

LI, PC, AS

8 × [Cisplatin/Adriamycin]; 2 × [Adriamycin/Doxorubicin]; 6 × [Navelbine/Carboplatin]

14

60

f

Lung cancer

PET

LI

6 × [Carboplatin/Cisplatin/Etoposid]

15

62

m

Stomach cancer

PET

LI, PE, AS

1 × [Irinothekan/5-FU/Folinacid]; 5 × [Etoposid/5-FU/Folinacid]

16

54

f

Ovarian cancer

CA 125

PC, AS, Figo IIIC

? × [Taxol/Carboplatin]

LU: lung metastases, LI: liver metastases, LN: lymph node metastases, BM: bone metastases; MI: metastasis in Mediastinum; PC: peritoneal cancerosis, AS: ascites, MPE: malign pleural effusion; LO: local progress; × [...]: cycles of chemotherapy

Schmidt et al. Nutrition & Metabolism 2011 8:54   doi:10.1186/1743-7075-8-54